Sinopharm Group Co. Ltd. (OTCMKTS:SHTDY) Sees Large Decline in Short Interest

Sinopharm Group Co. Ltd. (OTCMKTS:SHTDY) was the target of a significant decline in short interest in August. As of August 14th, there was short interest totaling 15,265 shares, a decline of 76.2% from the July 30th total of 64,023 shares. Based on an average trading volume of 128,100 shares, the short-interest ratio is currently 0.1 days.

Sinopharm Group Trading Up 0.4%

SHTDY stock opened at $10.06 on Friday. The firm has a 50 day moving average price of $10.69 and a 200-day moving average price of $11.83. Sinopharm Group has a 52-week low of $9.98 and a 52-week high of $14.87.

Sinopharm Group Company Profile

Sinopharm Group Co, Ltd. (OTCMKTS:SHTDY) is one of China’s largest integrated healthcare companies and an indirect subsidiary of the state-owned China National Pharmaceutical Group Co, Ltd. The company operates through two primary segments—pharmaceutical distribution and retail pharmacy—offering comprehensive supply chain solutions that span procurement, storage, transportation and sales of medical products. With a broad portfolio that includes prescription drugs, over-the counter medicines, medical devices and consumables, Sinopharm serves hospitals, clinics, retail pharmacies and other healthcare institutions across mainland China.

In its distribution business, Sinopharm leverages an extensive logistics network, comprising hundreds of distribution centers and thousands of delivery vehicles, to ensure timely delivery of pharmaceuticals under stringent temperature-controlled conditions.